Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Clara M Rosso-Fernández, Pilar Retamar, Belén Gutiérrez-Gutiérrez, Alvaro Pascual, Elena Salamanca, Vicente Merino, Luis Eduardo López-Cortés, Alicia Marín-Candón, Natalia Bustos de Godoy, Lorena López-Cerero, Lydia Barrera Pulido, Irene Borreguero Borreguero, María José León, Manuel Camean-Fernández
Format: article
Langue:EN
Publié: BMJ Publishing Group 2021
Sujets:
Medicine
R
Accès en ligne:https://doaj.org/article/505cc657de344c528b8d957a3dcaa1bc
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Documents similaires